التفاصيل البيبلوغرافية
| العنوان: |
A Randomized, Controlled Trial Comparing Tearcare ® and Cyclosporine Ophthalmic Emulsion for the Treatment of Dry Eye Disease (SAHARA) [Response To Letter]. |
| المؤلفون: |
Ayres BD; Private Practice, Philadelphia, PA, USA., Bloomenstein MR; Schwartz Laser Eye Center, Scottsdale, AZ, USA., Loh J; Loh Ophthalmology Associates, Miami, FL, USA., Chester T; Cleveland Eye Clinic, Brecksville, OH, USA., Saenz B; Rosenberg School of Optometry, San Antonio, TX, USA.; LASIK San Antonio, Kerrville, TX, USA., Ehegoyen J; Gordon Schanzlin New Vision Institute, La Jolla, CA, USA., Kannarr SR; Kannarr Eye Care, Pittsburg, KS, USA., Perez VL; Bascom Palmer Eye Institute, University of Miami, Miami, FL, USA., Rodriguez TC; Sight Sciences, Menlo Park, CA, USA., Dickerson JE Jr; Sight Sciences, Menlo Park, CA, USA.; North Texas Eye Research Institute, University of North Texas Health Science Center, Fort Worth, TX, USA. |
| المصدر: |
Clinical ophthalmology (Auckland, N.Z.) [Clin Ophthalmol] 2024 Mar 20; Vol. 18, pp. 885-886. Date of Electronic Publication: 2024 Mar 20 (Print Publication: 2024). |
| نوع المنشور: |
Journal Article; Comment |
| اللغة: |
English |
| بيانات الدورية: |
Publisher: Dove Medical Press Country of Publication: New Zealand NLM ID: 101321512 Publication Model: eCollection Cited Medium: Print ISSN: 1177-5467 (Print) Linking ISSN: 11775467 NLM ISO Abbreviation: Clin Ophthalmol Subsets: PubMed not MEDLINE |
| أسماء مطبوعة: |
Original Publication: Auckland : Dove Medical Press, c2007- |
| مستخلص: |
Competing Interests: BA, MB, JL, TC, BS, JE, and SK were Investigators and received research support for the study. BA is a consultant for Allergan and Sight Sciences. MB is a consultant for and reports honoraria from Allergan and Sight Sciences. JL is a consultant for Allergan and Sight Sciences and reports personal fees from Sun Ophthalmics, Alcon, and Bausch and Lomb, outside the submitted work. TC reports grant support, consulting, and speaking for Sight Sciences. BS is a consultant and speaker for Sight Sciences and Allergan. SK is a consultant and speaker for Allergan and a consultant for Sight Sciences. VP reports consulting fees from Sight Sciences, grants from Alcon; stock options from Claris; grants, personal fees from Novartis; personal fees from Dompe, Oyster Point, Oculis, Novaliq, Sun Pharma, Quidel, BrightStar and Kala; stock options from Trefoil; personal fees, stock options from Kuria, outside the submitted work. JD and TR are employees of Sight Sciences. There are no other relevant conflicts of interest in this communication. |
| التعليقات: |
Comment on: Clin Ophthalmol. 2024 Mar 13;18:817-818. (PMID: 38504933) |
| تواريخ الأحداث: |
Date Created: 20240325 Latest Revision: 20240325 |
| رمز التحديث: |
20240325 |
| مُعرف محوري في PubMed: |
PMC10961084 |
| DOI: |
10.2147/OPTH.S468297 |
| PMID: |
38525381 |
| قاعدة البيانات: |
MEDLINE |
PDF full text from Publisher 
Full Text Finder